New drug combo offers hope for bladder cancer patients who failed standard therapy
Disease control
Recruiting now
This study tests a new treatment for people with a high-risk type of bladder cancer that did not get better after standard BCG therapy. The treatment combines two chemotherapy drugs placed directly into the bladder with an immunotherapy drug given through a vein. The goal is to s…
Phase: PHASE2 • Sponsor: BLATAM • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC